|1.||Howe, Dale: 2 articles (07/2003 - 06/2003)|
|2.||Heinzen, Robert A: 2 articles (07/2003 - 06/2003)|
|3.||Barák, Imrich: 2 articles (07/2003 - 06/2003)|
|4.||Doud, Melissa S: 1 article (01/2014)|
|5.||Zhang, Muqing: 1 article (01/2014)|
|6.||Powell, Charles A: 1 article (01/2014)|
|7.||Yang, Chuanyu: 1 article (01/2014)|
|8.||Duan, Yongping: 1 article (01/2014)|
|9.||Guo, Ying: 1 article (01/2014)|
|10.||Jiang, J: 1 article (01/2012)|
03/01/1979 - "Combinations of carbenicillin plus an aminoglycoside antibiotic are effective for the treatment of infections in neutropenic patients."
07/14/1979 - "The clinical study was carried out on a double blind basis versus a standard reference (indanyl ester of carbenicillin) in 26 patients and showed the electivity of the antibiotic in the oral treatment of urinary infections under well tolerated conditions."
07/01/1979 - "The study on sensitivity of clinical strains of the causative agents of purulent infections to carbenicillin showed that 34.6% of the staphylococcal strains, 48.1% of the E. "
10/01/1972 - "[Clinical study of carbenicillin in pyocyanic infections in children]."
11/01/1971 - "[Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa]."
|2.||Urinary Tract Infections (Urinary Tract Infection)
09/01/1971 - "[Effective treatment of urinary tract infection with carbenicillin]."
01/01/1974 - "[Carbenicillin in the treatment of kidney and urinary tract infections from the clinical and bacteriological viewpoints]."
05/01/1973 - "Long-term oral carbenicillin therapy in complicated urinary-tract infections."
05/01/1973 - "The treatment of urinary-tract infections with an oral carbenicillin."
06/01/1972 - "[Treatment of urinary tract infections with a massive dose of carbenicillin (CB-PC)]."
01/01/1989 - "We evaluated whether carbenicillin causes deterioration of platelet function in patients with cancer and whether mezlocillin causes similar effects on platelets from normal subjects or from patients with cancer. "
01/01/1989 - "Comparative effects of mezlocillin and carbenicillin on platelet function and thromboxane generation in patients with cancer."
03/01/1982 - "Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer."
01/01/1989 - "Carbenicillin and mezlocillin are widely used for treatment of Pseudomonas infections in patients with cancer. "
05/01/1979 - "Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients."
07/01/1978 - "Similar reductions for the carbenicillin study group in fever index and average total hospital stay were also noted. "
03/01/1982 - "Fever occurred in 48 per cent of the placebo and in 17 per cent of the carbenicillin groups. "
12/19/1980 - "Random allocation of 22 patients with benign and malignant diseases with neutrophil counts of up to 1 X 10(9)/l blood and probably infection-caused fever of more than 38 degrees C to intravenous treatment with one of the following antibiotic combinations was performed: carbenicillin (6 g/m(2) . "
02/01/1979 - "The current recommended fever regimen would be carbenicillin (or ticarcillin) with an aminoglycoside. "
05/01/1978 - "The combination of carbenicillin plus cefamandole was administered to 88 patients with cancer during 116 evaluable episodes of fever. "
04/30/1983 - "In both regimens carbenicillin was added during neutropenia (71% of all episodes: groups C and D). "
05/01/1979 - "To overcome the adverse effects of neutropenia, tobramycin was given by continuous infusion and combined with intermittent carbenicillin. "
08/01/1977 - "Review of the hematologic complications of cephalosporins, particularly agranulocytosis, suggests an interesting association between carbenicillin-induced neutropenia and previous administration of cephalosporins."
12/19/1980 - "Mezlocillin thus leads to equal success of treatment in febrile neutropenia as the double dose of carbenicillin when both antibiotics are combined with the same aminoglycoside."
01/01/1996 - "A randomized clinical trial was performed in children with cancer, fever and neutropenia, to evaluate the efficacy of amikacin once daily versus thrice daily dosing plus carbenicillin in both groups. "
|6.||Anti-Bacterial Agents (Antibiotics)
|7.||Cefoxitin (Cefoxitin Sodium)
|10.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|3.||Drug Therapy (Chemotherapy)